In tests on patients with breast cancer who were being given chemotherapy drugs doxorubicin (an injection) and cyclophosphamide (a tablet), more hairs grew in areas treated with the gel. The hair was ...

Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the risk ...

Battling cancer and costs Dr Shripad Banavali's research on an inexpensive treatment has given hope to thousands of poor patients INITIATIVE Low-cost cancer therapy FACES BEHIND I ...

Jaguar Health announced that its product, cofelemer delayed-release tablets (Canalevia-CA1; Jaguar Health), received approved ...

The N-AVD regimen showed improved progression-free survival and lower toxicity than BV-AVD in advanced Hodgkin lymphoma, ...

Rituximab and cyclophosphamide are equally effective in achieving remission or low disease activity rates in childhood-onset antineutrophil cytoplasmic antibody–associated vasculitis (AAV), and ...

Get detailed information on Cyclophosphamide, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy.

About Chemotherapy-induced Diarrhea (CID ... Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled ...

Canalevia ®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA By prescription only, Canalevia-CA1 is a canine-specific ...

It was excruciating it’s like torture.” He developed a strategy of aiming to get through one minute of chemotherapy treatment at a time to cope with the pain. In the same interview ...

Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma In the article accompanying this editorial, Jensen et al 20 provide an update on the READ ...